Evidence-Based Best Practices: 18F-FDG PET Staging of Newly Diagnosed Breast Cancer

Clin Nucl Med. 2021 Jul 1;46(7):569-570. doi: 10.1097/RLU.0000000000003690.

Authors

Gary A Ulaner¹, Heather A Jacene², Ashwin Singh Parihar³, David Groheux⁴

Affiliations

¹ From the Molecular Imaging and Therapy, Hoag Family Cancer Institute, Newport Beach, CA.
² Departments of Imaging and Radiology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA.
³ Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO.
⁴ Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France.

PMID: 34028402
DOI: 10.1097/RLU.0000000000003690

No abstract available

Publication types

Comment

MeSH terms

Breast Neoplasms* / diagnostic imaging
Female
Fluorodeoxyglucose F18*
Humans
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography

Substances

Fluorodeoxyglucose F18